Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in US children aged 18-59 months
- 17 August 1991
- journal article
- Published by Elsevier in The Lancet
- Vol. 338 (8764) , 395-398
- https://doi.org/10.1016/0140-6736(91)91028-s
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 childrenThe Pediatric Infectious Disease Journal, 1991
- Bacterial Meningitis in the United States, 1986: Report of a Multistate Surveillance StudyThe Journal of Infectious Diseases, 1990
- The Immunogenicity of Hemophilus influenzae Type B Polysaccharide--Neisseria meningitidis Group B Outer Membrane Protein Complex Vaccine in Infants and Young ChildrenThe Journal of Infectious Diseases, 1989
- Efficacy of Haemophilus influenzae type b capsular polysaccharide vaccineThe Pediatric Infectious Disease Journal, 1988
- Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of ageThe Journal of Pediatrics, 1987
- Primary invasive Haemophilus influenzae type b disease: A population-based assessment of risk factorsThe Journal of Pediatrics, 1986
- Risk factors for primary invasive Haemophilus influenzae disease: Increased risk from day care attendance and school-aged household membersThe Journal of Pediatrics, 1985
- Hemophilus influenzae Type b DiseasePublished by American Medical Association (AMA) ,1984
- Prevention ofHemophilus influenzaeType B Bacteremic Infections with the Capsular Polysaccharide VaccineNew England Journal of Medicine, 1984
- Risk Factors in Bacterial Meningitis: Charleston County, South CarolinaThe Journal of Infectious Diseases, 1973